Parameters | Group 1 (open drainage) | Group 2 (closed drainage) | p value |
---|---|---|---|
Number of patients | 56 | 200 | Â |
Donor age (years) | 46.5 (24–74) | 49.0 (15–76) | 0.7 (ns) |
Donor gender (m:f) | 29:27 | 96:104 | 0.4 (ns) |
Donor CMV-positive | 34 (61Â %) | 110 (55Â %) | 0.2 (ns) |
Donor ICU stay (days) | 6 (1–16) | 5 (1–14) | 0.7 (ns) |
Donor steatosis hepatis | |||
 No | 42 (75 %) | 161 (80 %) | 0.8 (ns) |
 Moderate | 11 (20 %) | 35 (17.5 %) | 0.9 (ns) |
 Severe | 3 (5 %) | 4 (2 %) | 0.8 (ns) |
Recipient age (years) | 51.4 (12–68) | 52.6 (16–67) | 0.3 (ns) |
Recipient gender (m:f) | 44:12 | 153:47 | 0.9 (ns) |
Recipient CMV-positive | 37 (66Â %) | 141 (70Â %) | 0.3 (ns) |
CMV (donor+/recip.−) | 12 (21 %) | 38 (19 %) | 0.8 (ns) |
MELD score | 17.0 (8–39) | 16 (7–40) | 0.3 (ns) |
Body Mass Index | 25.9 (17.4–35.4) | 26.6 (18.5–36.2) | 0.9 (ns) |
Underlying disease | |||
 Hepatitis B | 5 (9 %) | 13 (7 %) | 0.4 (ns) |
 Hepatitis C | 13 (23 %) | 47 (24 %) | 0.6 (ns) |
 Cryptogenic | 2 (4 %) | 12 (6 %) | 0.4 (ns) |
 Primary biliary cirrhosis | 1 (2 %) | 9 (4.5 %) | 0.3 (ns) |
 Biliary atresia | 0 | 1 (0.5 %) | 0.8 (ns) |
 Sclerosing cholangitis | 1 (2 %) | 5 (2.5 %) | 0.6 (ns) |
 Autoimmune hepatitis | 1 (2 %) | 4 (2 %) | 0.7 (ns) |
 Metabolic | 0 | 11 (5.5 %) | 0.1 (ns) |
 Acute liver failure | 4 (7 %) | 14 (7 %) | 0.6 (ns) |
 Chronic alcoholic | 29 (52 %) | 84 (42 %) | 0.5 (ns) |
Presence of HCCa | 24 (43Â %) | 69 (34.5Â %) | 0.1 (ns) |
Child-Pugh score | |||
 Child A | 10 (18 %) | 42 (21 %) | 0.9 (ns) |
 Child B | 32 (57 %) | 110 (55 %) | 0.9 (ns) |
 Child C | 14 (25 %) | 48 (24 %) | 0.8 (ns) |
Previous abdominal surgery | 24 (43Â %) | 85 (42.5Â %) | 0.5 (ns) |
Preoperative portal vein thrombosis | 2 (4Â %) | 10 (5Â %) | 0.5 (ns) |
Retransplantation | 3 (5Â %) | 15 (7.5Â %) | 0.4 (ns) |